Senior Manager / Associate Director, HCP Marketing (US)

Cambridge, MA (Hybrid)

$155K/yr – $225K/yrSenior Level3+ years expFull time

Posted 1 day ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the U.S. HCP marketing strategy execution for apitegromab, ensuring cross-functional alignment and compliant promotional tactics across channels; collaborate with field teams and agencies to deliver integrated campaigns while building cross-functional partnerships.

Commercial and Regulatory alignment across initiatives
Drive compliant HCP messaging and cross-functional collaboration

Job Description

Responsibilities

U.S. HCP Execution
- Support execution of the U.S. HCP brand strategy for apitegromab, grounded in deep understanding of the SMA landscape, unmet need, and clinical data.
- Translate strategy into high-quality, compliant HCP promotional tactics across personal and non-personal channels.
- Partner with field-based team members to ensure strong integration between HCP marketing and field execution.
- Collaborate with agency partners and vendors to deliver best-in-class creative and execution.
Cross-Functional Leadership
- Serve as a connector across the U.S. Commercial Team, collaborating with Medical Affairs, Market Access, Patient Services, Regulatory, Legal, and Compliance.
- Build strong relationships with cross-functional partners in order to ensure brand continuity across all HCP-facing materials and tactics.

Requirements

Bachelor’s degree required; advanced degree preferred.
3+ years of experience in pharmaceutical or biotechnology marketing, with experience in U.S. HCP marketing or Medical Education preferred
MLR (or equivalent) experience strongly preferred.
Understanding and experience navigating compliant HCP messaging.
Strong strategic mindset with hands-on execution capability.
Experience working in matrixed, cross-functional teams in a fast-paced environment.
Excellent communication, influence, and stakeholder-management skills.
Experience in neurology, neuromuscular disease, or rare disease preferred.
Willingness to travel as needed (anticipated up to ~30%).

Preferred

Advanced degree preferred.
Experience in neurology, neuromuscular disease, or rare disease preferred.

Scholar Rock

4.1 Glassdoor

Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock on X.For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy/

Founded in 2012

Cambridge, Massachusetts, USA

323 employees

scholarrock.com

84% recommend to a friend

100% CEO approval